Loading insider details...
Latest Form 4 (Mar 2, 2026): Grant/Award of 190,034 GENB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 2, 2026 | Generate Biomedicines, Inc. (GENB) | Grant/Award | 190,034 | n/a |
| Mar 4, 2022 | BAXTER INTERNATIONAL INC (BAX) | Grant/Award | 6,688 | n/a |
| Feb 14, 2022 | BAXTER INTERNATIONAL INC (BAX) | Grant/Award | 1,604 | n/a |
| Nov 3, 2021 | BAXTER INTERNATIONAL INC (BAX) | Exercise/Conversion | 21,450 | $1.09M |
| Aug 4, 2021 | BAXTER INTERNATIONAL INC (BAX) | Exercise/Conversion | 19,800 | $1.01M |
| Mar 5, 2021 | BAXTER INTERNATIONAL INC (BAX) | Grant/Award | 63,360 | n/a |
| Feb 18, 2021 | BAXTER INTERNATIONAL INC (BAX) | Grant/Award | 881 | n/a |
| Nov 4, 2020 | BAXTER INTERNATIONAL INC (BAX) | Exercise/Conversion | 47,001 | $2.39M |
| Apr 1, 2020 | BAXTER INTERNATIONAL INC (BAX) | Purchase | 9,780 | $803.8K |
| Mar 23, 2020 | BAXTER INTERNATIONAL INC (BAX) | Grant/Award | 3,184 | n/a |